IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q2 2021 Holdings

Filed 2021-08-16 | 14 holdings | $291.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$222.7M643,00076.5%
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$67.4M4,261,00023.2%
Alkermes PLC(ALKS)SHSG01767105$291.1K11,870,0000.1%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$210.9K16,390,0000.1%
Gilead Sciences Inc(GILD)COM375558103$185.7K2,697,4000.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$119.5K650,4400.0%
Innoviva Inc(INVA)COM45781M101$86.0K6,414,0000.0%
Mersana Therapeutics IncCOM59045L106$54.4K4,005,6000.0%
VOR Biopharma IncCOM929033108$13.2K707,0100.0%
Sarissa Capital Acquisitn CoW EXP 10/23/202G7823W110$5.0K3,333,3330.0%
Regulus Therapeutics IncCOM NEW75915K200$1.5K1,851,8510.0%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$1771,0000.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$1611,0000.0%
Intercept Pharmaceuticals Inc(ICPTUSD)COM45845P108$189500.0%